20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Irinotecan hydrochloride trihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2017-234 - Rev 02
This Chemical Type CEP, issued on September 02, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2675 associated with this CEP further emphasizes